EUVIMEDEUVIMED entdecken
Open Access

Depletion of DNTTIP2 Induces Cell Cycle Arrest in Pancreatic Cancer Cells

Masato Yoshizawa, Atsushi Shiozaki, Eishi Ashihara

Cancer Genomics - Proteomics · 2024

DOI: 10.21873/cgp.20426 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Genomics - Proteomics, 2024. Verfasst von Masato Yoshizawa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Clinical and Translational Physiology, Kyoto Pharmaceutical University, Kyoto, Japan; kd20011@ms.kyoto-phu.ac.jp. Hauptthemen laut MEDLINE: Matrix Attachment Region Binding Proteins, Pancreatic Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Pancreatic cancer is one of the most lethal malignant cancers worldwide and the seventh most common cause of cancer-related death in both sexes. Herein, we analyzed open access data and discovered that expression of a gene called deoxynucleotidyltransferase terminal-interacting protein 2 (DNTTIP2) is linked to prognosis of pancreatic ductal adenocarcinoma (PDAC). We then elucidated the role of DNTTIP2 in the proliferation of pancreatic cancer cells in vitro. MATERIALS AND METHODS: A WST-8 assay, cell cycle analysis, Annexin-V staining, quantitative reverse transcription-PCR, and western blot analysis were conducted to assess cell proliferation, cell cycle, apoptosis, and expression of DNTTIP2 mRNA and protein, respectively, in DNTTIP2-depleteted MIA-PaCa-2 and PK-1 cells. RESULTS: Depletion of DNTTIP2 induced G1 arrest in MIA-PaCa-2 cells by decreasing expression of special AT-rich sequence binding protein 1 (SATB1) and cyclin-dependent kinase 6 (CDK6). In addition, depletion of DNTTIP2 induced G2 arrest in PK-1 cells by decreasing expression of CDK1. Depletion of DNTTIP2 did not induce apoptosis in MIA-PaCa-2 or PK-1 cells. CONCLUSION: DNTTIP2 is involved in proliferation of pancreatic cancer cells. Thus, DNTTIP2 is a potential target for inhibiting progression of pancreatic cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Matrix Attachment Region Binding ProteinsPancreatic NeoplasmsFemaleHumansMaleApoptosisCell CycleCell Cycle CheckpointsCell Line, TumorCell ProliferationTranscription FactorsRNA-Binding Proteins

Stichwörter der Autor:innen

CDK1CDK6DNTTIP2Pancreatic cancerSATB1cells

Substanzen

Matrix Attachment Region Binding ProteinsTranscription FactorsSATB1 protein, humanDNTTIP2 protein, humanRNA-Binding Proteins

Autor:innen und Institutionen

  • Laboratory of Clinical and Translational Physiology, Kyoto Pharmaceutical University, Kyoto, Japan; kd20011@ms.kyoto-phu.ac.jp.
  • Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Laboratory of Clinical and Translational Physiology, Kyoto Pharmaceutical University, Kyoto, Japan; ash@mb.kyoto-phu.ac.jp.

Zitieren

APA

Yoshizawa, M., Shiozaki, A., & Ashihara, E. (2024). Depletion of DNTTIP2 Induces Cell Cycle Arrest in Pancreatic Cancer Cells. Cancer Genomics - Proteomics. https://doi.org/10.21873/cgp.20426

Vancouver

Yoshizawa M, Shiozaki A, Ashihara E. Depletion of DNTTIP2 Induces Cell Cycle Arrest in Pancreatic Cancer Cells. Cancer Genomics - Proteomics. 2024. doi:10.21873/cgp.20426

BibTeX
@article{Yoshizawa2024,
  author = {Yoshizawa, Masato and Shiozaki, Atsushi and Ashihara, Eishi},
  title = {Depletion of DNTTIP2 Induces Cell Cycle Arrest in Pancreatic Cancer Cells},
  journal = {Cancer Genomics - Proteomics},
  year = {2024},
  doi = {10.21873/cgp.20426}
}
Kostenlos starten →